Overexpression of calmodulin in pancreatic β cells induces diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 19, Issue 9, 2008, Pages 1701-1711

  Yuzawa, Yukio ^a   Niki, Ichiro ^b   Kosugi, Tomoki ^a   Maruyama, Shoichi ^a   Yoshida, Futoshi ^c   Takeda, Motohiro ^d   Tagawa, Yoshiaki ^d   Kaneko, Yukiko ^c   Kimura, Toshihide ^c   Kato, Noritoshi ^a   Yamamoto, Jyunichiro ^a   Sato, Waichi ^a,e   Nakagawa, Takahiko ^e   Matsuo, Seiichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OITA UNIVERSITY   (Japan)

^c Aichi Prefectural Colony Central Hospital   (Japan)

^d SANWA KAGAKU KENKYUSHO CO LTD   (Japan)

^e UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALMODULIN; COLLAGEN TYPE 4; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; THROMBOMODULIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY DENSITY; DIABETIC NEPHROPATHY; ENDOTHELIAL DYSFUNCTION; HYALINE DEGENERATION; HYPERGLYCEMIA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; TRANSGENIC MOUSE; ANIMAL; ARTERIOLE; BLOOD; CAPILLARY; DISEASE MODEL; FEMALE; IMMUNOHISTOCHEMISTRY; KIDNEY; METABOLISM; PATHOLOGY; URINE; VASCULARIZATION;

ANIMALS; ARTERIOLES; CALMODULIN; CAPILLARIES; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; INSULIN-SECRETING CELLS; KIDNEY; MICE; MICE, TRANSGENIC; NITRIC OXIDE SYNTHASE TYPE III; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; THROMBOMODULIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 54749108433     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2006121358     Document Type: Article

References (43)

1. Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J: Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330: 15-18, 1994
2. Krolewski M, Eggers PW, Warram JH: Magnitude of end-stage renal disease in IDDM: A 35-year follow-up study. Kidney Int 50: 2041-2046, 1996
3. Makino H, Nakamura Y, Wada J: Remission and regression of diabetic nephropathy. Hypertens Res 26: 515-519, 2003
4. Adler S: Diabetic nephropathy: Linking histology, cell biology, and genetics. Kidney Int 66: 2095-2106, 2004
5. Gunter W, Ziyadeh FN: Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 56: 393-405, 1999
6. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R: Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 14: 439-447, 2000
7. Haneda M, Koya D, Isono M, Kikkawa R: Overview of glucose signaling in mesangial cells in diabetic nephropathy. J Am Soc Nephrol 14: 1374-1382, 2003
8. Ma LJ, Fogo AB: Model of robust induction of glomerulosclerosis in mice: Importance of genetic background. Kidney Int 64: 350-355, 2003
9. Breyer MD, Bottinger E, Brosius FC III, Coffman TM, Harris RC, Heilig CW, Sharma K: Mouse models of diabetic nephropathy. J Am Soc Nephrol 16: 27-45, 2005
10. Zheng F, Plati AR, Potier M, Schulman Y, Berho M, Banerjee A, Leclercq B, Zisman A, Striker LJ, Striker GE: Resistance to glomerulosclerosis in B6 mice disappears after menopause. Am J Pathol 162: 1339-1348, 2003
11. Kosugi T, Yuzawa Y, Sato W, Kawai H, Matsuo S, Takei Y, Muramatsu T, Kadomatsu K: Growth factor midkine is involved in the pathogenesis of diabetic nephropathy. Am J Pathol 168: 9-19, 2006
12. 2+-dependent apoptosis of pancreatic β cells, which can be prevented by inhibition of nitric oxide synthase. Lab Invest 82: 1229-1239, 2002
13. Epstein PN, Overveek PA, Means AR: Calmodulin-induced early-onset diabetes in transgenic mice. Cell 58: 1067-1073, 1989
14. Epstein PN, Riber TJ, Decker GL, Yaney G, Means AR: Elevated β-cell calmodulin produces unique insulin secretory defect in transgenic mice. Endocrinology 130: 1387-1393, 1992
15. Tsunekawa S, Miura Y, Yamamoto N, Itoh Y, Ariyoshi Y, Senda T, Oiso Y, Niki I: Systemic administration of pituitary adenylate cyclase-activating polypeptide maintains beta-cell mass and retards onset of hyperglycemia in beta-cell-specific calmodulin-overexpressing transgenic mice. Eur J Endocrinol 152: 805-811, 2005
16. Tsunekawa S, Yamamoto N, Tsukamoto K, Itoh Y, Kaneko Y, Kimura T, Ariyoshi Y, Miura Y, Oiso Y, Niki I: Protection of pancreatic beta cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies. J Endocrinol 193: 65-74, 2007
17. Carlson EC, Audette JL, Klevay LM, Nguyen H, Epstein PN: Ultrastructural and functional analysis of nephropathy in calmodulin-induced diabetic nephropathy. Anat Rec 247: 9-19, 1997
18. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS: Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB. Kidney Int 61: 186-194, 2002
19. Sugimoto H, Shikata K, Matsuda M, Kushiro M, Hayashi Y, Hiraguchi K, Wada J, Makino H: Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia 41: 1426-1434, 1998
20. Goligorsky MS, Chen J, Brodsky S: Endothelial cell dysfunction leading to diabetic nephropathy focus on nitric oxide. Hypertension 37: 744-748, 2001
21. Komers R, Schutzer WE, Reed JF, Lindsley JN, Oyama TT, Buck DC, Mader SL, Anderson S: Altered endothelial nitric oxide synthase targeting and conformation and caveolin-expression in the diabetic kidney. Diabetes 55: 1651-1659, 2006
22. Jansen EB, Gundersen HJ, Osterby R: Determination of membrane thickness distribution from orthogonal intercepts. J Microsc 115: 19-33, 1979
23. Nakagawa T, Sato W, Sautin YY, Glushakova O, Croker B, Atkinson MA, Tisher CC, Johnson RJ: Uncoupling of vascular endothelial growth factor with nitric oxide as a mechanism for diabetic vasculopathy. J Am Soc Nephrol 17: 736-745, 2006
24. Zheng F, Striker GE, Esposito C, Lupia E, Striuker LJ: Strain differences rather than hyperglycemia determine the severity of glomerulosclerosis in mice. Kidney Int 54: 1999-2007, 1998
25. Nishi S, Ueno M, Hisaki S, Iino N, Iguchi S, Oyama Y, Imai N, Arakawa M, Grjyo F: Ultrastructural characteristics of diabetic nephropathy. Med Electron Microsc 33: 65-73, 2000
26. Bussolati B, Dunk C, Grohman M, Kontos CD, Mason J, Armed A: Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol 159: 993-1008, 2001
27. Grosskreutz CL, Anand-Apte B, Duplaa C, Quinn TP, Terman BI, Zetter B, D'Amore PA: Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res 58: 128-136, 1999
28. Sealey LE, Blumenfeld JD, Bell GM, Pecker MS, Sommers SC, Laragh JH: On the renal basis for essential hypertension: Nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship. J Hypertens 6: 763-777, 1988
29. Brenner BM: Nephrology forum: Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 23: 647-655, 1983
30. Cha DR, Kim NH, Yoon JW, Jo SK, Cho WY, Kim HK, Won NH: Role of vascular endothelial growth factor in diabetic nephropathy. Kidney Int 58[Suppl 77]: S-104-S-112, 2000
31. De Vriese AS, Tilton RG, Elger M, Stephan CC, Kritz W, Lameire NH: Antibodies against endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 12: 993-1000, 2001
32. Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, Schrijvers BF, Tilton RG, Rasch R: Ameriolation of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51: 3090-3094, 2002
33. Schrijvers B, Flyvbjerg A, de Vriese S: The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 65: 2003-2017, 2004
34. Onozaki A, Midorikawa S, Sanada H, Hayashi Y, Baba T, Katoh T, Watanabe T: Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: Inhibitory effects of thiazolidinedione. Biochem Biophys Res Commun 317: 24-29, 2004
35. Komers R, Anderson S: Paradox of nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol 284: F1121-F1137, 2003
36. Ziche M, Morbideli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R: Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99: 2625-2634, 1997
37. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M: Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108: 1341-1348, 2001
38. Da Silva-Azevedo L, Baum O, Zakrzewicz A, Pries AR: Vascular endothelial growth factor is expressed in endothelial cells isolated from skeletal muscles of nitric oxide synthase knockout mice during prazosin-induced angiogenesis. Biochem Biophys Res Commun 297: 1270-1276, 2002
39. Kang D, Nakagawa T, Feng L, Johnson RJ: Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol 161: 239-248, 2002
40. Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, Campbell-Thompson M, Yuzawa Y, Atkinson MA, Johnson RJ, Croker B: Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 18: 539-550, 2007
41. Yuzawa Y, Brentjens JR, Brett L, Caldwell PR, Esposito C, Fukatsu A, Godman G, Stern D, Andres G: Antibody-mediated redistribution and shedding of endothelial antigens in the rabbit. J Immunol 150: 5633-5646, 1993
42. Kang DH, Joly AH, Oh SW, Hugo C, Kerjaschki D, Gordon KL, Mazzali M, Jefferson JA, Hughes J, Madsen KM, Schriner G, Johnson RJ: Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 12: 1434-1447, 2001
43. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R: Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factorinduced angiogenesis. J Clin Invest 99: 2625-2634, 1997